HC restrains 4 pharma firms from making, selling Novartis Sacubitril, Valsartan tablets Ruchika Sharma2 Nov 2021 6:09 PM ISTNew Delhi: In a major relief to Novartis, the Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or...
Novartis Scemblix gets USFDA nod for chronic myeloid leukemia Ruchika Sharma31 Oct 2021 10:00 AM ISTBasel: Novartis has recently announced that the US Food and Drug Administration (FDA) has approved Scemblix (asciminib) for the treatment of chronic...
Setback: Novartis lung cancer drug fails phase 3 study CANOPY-1 Ruchika Sharma26 Oct 2021 10:00 AM ISTBasel: Novartis has announced that the CANOPY-1 Phase III study did not demonstrate the statistically significant primary endpoints of overall...
CDSCO panel junks Novartis proposed clinical trial of oral treatment for C3 glomerulopathy Medical Dialogues Team25 Oct 2021 4:49 PM ISTNew Delhi: In a setback to pharma major Novartis, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization...
Novartis proposal to market Inclisiran with clinical trial waiver rejected by CDSCO panel Medical Dialogues Team24 Oct 2021 11:30 AM ISTNew Delhi: Rejecting Novartis Healthcare's proposal to import and market Inclisiran Solution for Injection with a local clinical trial waiver,...
Novartis, BioNTech ink pact to support fill, finish of mRNA Pfizer-BioNTech COVID vaccine Ruchika Sharma22 Oct 2021 2:54 PM ISTBasel: Novartis has announced that the company has signed an initial agreement to leverage its manufacturing capacity and capabilities to address the...
New toxic drug impurities detected in some heart pills in US: Bloomberg Ruchika Sharma15 Oct 2021 9:15 AM ISTNew Delhi: Over the past three years, millions of blood pressure pills that contain a probable carcinogen have been recalled around the world. As...
NPPA rejects Novartis plea to discontinue painkiller Voltaflam Medical Dialogues Team18 Sept 2021 5:04 PM ISTNew Delhi: Rejecting Novartis India Limited's proposal for discontinuation of scheduled formulation viz., Voltafalm 50mg, the National Pharmaceutical...
Novartis LNA043 for knee osteoarthritis gets USFDA fast track status Ruchika Sharma5 Sept 2021 10:15 AM ISTLNA043 is a ANGPTL3 agonist that targets damaged cartilage and modulates several pathways involved in cartilage regeneration.
Novartis pediatric psoriasis treatment Cosentyx approved in China Ruchika Sharma18 Aug 2021 3:46 PM ISTBasel: Novartis has recently announced that the China National Medical Products Administration (NMPA) has further approved Cosentyx (secukinumab) for...
Cipla bags USFDA nod for generic version of Durezol Ruchika Sharma12 Aug 2021 2:15 PM ISTMumbai: Drug major, Cipla Limited, today announced that the company has received final approval for its Abbreviated New Drug Application (ANDA) for...
Novartis moves court against Roche seeking Rs 1565 crore overpaid amount in patent licensing pact Medical Dialogues Team1 July 2021 5:23 PM ISTNew Delhi: Accusing Roche of illegally pocketing fee from a 16-year-old patent licensing contract, Novartis has filed a lawsuit in U.S. District Court...
